Search for: "Actavis Pharma"
Results 161 - 180
of 243
Sorted by Relevance
|
Sort by Date
24 Mar 2014, 10:39 am
Big Pharma On the Move The largest Big Pharma companies that make and market Low T medical products are: Abbvie, Inc. [read post]
7 Mar 2022, 12:44 am
However, as noted in the Finnish decision, CJEU case law has not yet harmonised interpretation of Article 3(a) under Royalty Pharma and its previous interpretations of Article 3(c), as in Actavis I (C-443/12) and Actavis II (C-577/13) (IPKat).The referralThe Supreme Court of Ireland referred 4 questions to the CJEU, the full text of which are provided in full below* ([2022] IESC 11). [read post]
28 May 2018, 7:53 am
Actavis. [read post]
16 May 2023, 7:51 am
Patent No. 10,130,589 (the ‘589 patent), assigned to UCB Pharma GmbH and LTH Lohman Therapie-Systeme AG (collectively, “UCB”). [read post]
3 Jun 2015, 9:55 am
Actavis, Inc., 133 S. [read post]
9 Mar 2015, 12:23 pm
.* Warner-Lambert v Actavis Mark 4: harmony between parties in ‘lyrical’ patent disputeLast Thursday, Jeremy reported a High Court Order obtained by Warner-Lambert (part of the Pfizer group) mandating the NHS to release guidance about the prescribing of pregabalin (Warner-Lambert Company, LLC v Actavis Group PTC EHF & Others[2015] EWHC 485 (Pat) (02 March 2015)) [on which see the IPKat earlier posts, here and here]. [read post]
1 May 2010, 9:45 am
., and American Home Products Corporation, and Schwarz Pharma, Inc. [read post]
4 Mar 2009, 11:00 pm
(Spicy IP) Kenya enacts Biosafety Act 2/2009 regulating activities in GMOs, establishing National Biosafety Authority (Afro-IP) US: BIO meets the press: economic health of the biotech industry; follow-on biologics; patent reform (Patent Docs) (Patent Docs) (Intellectual Property Watch) US: Obama touts generic biologics to lower drug costs (Law360) US: Genentech announces victory in Cabilly re-examination (Patent Docs) US: Federal judge rejects Scruggs family’s bid to reconsider summary… [read post]
22 Sep 2019, 11:48 pm
The CJEU ruling in C- 650/17 (Royalty Pharma) and C-114/18 (Sandoz) is very much welcome, and we surely hope it leads us to clarity and not deeper in the mist of SPC interpretation. [read post]
27 Dec 2022, 4:33 pm
Octrooicentrum Nederland (C-484/12) and Actavis v. [read post]
9 Feb 2015, 1:15 am
* Warner-Lambert v Actavis Mark 2, still at first instance: more on Swiss claims, Skinny Labels, and no StrikeoutDarren covers another Arnoldian decision in Warner-Lambert Company, LLC v Actavis Group Ptc EHF & Others [2015] EWHC 223 (Pat). [read post]
2 Mar 2015, 2:43 pm
. * Warner-Lambert v Actavis Mark 3: a "lyrical" solution to a painful patent disputeAfter the Patents Court ruling of Mr Justice Arnold in Warner-Lambert Company, LLC v Actavis Group Ptc EHF & Others, which Darren reported here, Jeremy has got some news to break on that painful patent war.* Blind faith not enough when proving bad faith: a case of ColourblindnessValentina reports on a fresh trade mark dispute that the General Court has just decided, Pangyrus Ltd v… [read post]
26 Jan 2015, 4:03 am
* Pharma and biotech patents: a law unto themselves -- and a litigation conference to match? [read post]
23 Feb 2015, 2:55 am
Never too late 32 [week ending Sunday 8 February] –- Brazilian PTO’s delays | The Research Handbook on International Intellectual Property reviewed | Laura Smith-Hewitt | IP, women and leadership: the poll responses | Decline of West’s trust in innovation | Wikipedia public domain photos |CJEU in Case C-383/12 P Environmental Manufacturing LLP v OHIM | The Nordic IP Forum | The future of EPO’s BoA | Warner-Lambert v… [read post]
18 Nov 2018, 7:39 am
In her comment Lord Kitchin applies the "markedly different" infringement approach in Actavis v Eli Lilly in Icescape v Ice-World, InternKat Rose analyses this recent case to determine whether Lord Kitchin approached any of the unresolved issues left in the Actavis v Eli Lilly case.CopyrightLast year The IPKat reported on two new important referrals to the Court of Justice of the European Union (CJEU) from Germany. [read post]
31 May 2015, 3:47 am
Bio and pharma patent attorneys have had an entertaining few months following the exploits of Swiss-style claims in the Courts of England and Wales. [read post]
21 Jul 2017, 3:14 am
The Düsseldorf Regional Court awarded pharma company Merck a compulsory licence to produce Isentress, an HIV-treatment drug. [read post]
6 Feb 2019, 6:12 am
| The IP term (thus far) of the millennium: the curious story of the adoption of "patent troll" and "internet trolling" | No pain, no gain: Plausibility in Warner-Lambert v Actavis | Testing the boundaries of subjectivity: Infringement of Swiss-type claims in Warner-Lambert v Actavis | Is SPINNING generic? [read post]
23 Jun 2013, 8:58 pm
Guest Posts We received two interesting and informative guest posts on the Myriad and Actavis cases. [read post]
9 Jun 2014, 11:25 am
Last month, as reported by the Los Angeles Times, the California counties of Orange and Santa Clara sued Actavis, Endo Health Solutions Inc., Johnson & Johnson's Janssen Pharmaceuticals, Purdue Pharma and Teva Pharmaceutical Industries' Cephalon Inc. for causing the national prescription drug epidemic. [read post]
